Variant report

Variant	esv3447018
Chromosome Location	chr12:568191-570739
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr12:569939-570255	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr12:570572-570903	HepG2	liver:	n/a	n/a
3	BHLHE40	chr12:568683-568808	K562	blood:	n/a	n/a
4	CEBPB	chr12:568214-568497	A549	lung:	n/a	n/a
5	CEBPB	chr12:568275-568467	K562	blood:	n/a	n/a
6	CEBPB	chr12:568214-568554	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr12:568309-568542	HepG2	liver:	n/a	n/a
8	CEBPB	chr12:568253-568483	HepG2	liver:	n/a	n/a
9	CEBPB	chr12:568205-568608	MCF-7	breast:	n/a	n/a
10	CHD2	chr12:568587-568985	H1-hESC	embryonic stem cell:	n/a	n/a
11	CREB1	chr12:568572-569088	H1-hESC	embryonic stem cell:	n/a	n/a
12	CREB1	chr12:568611-569201	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr12:568840-568990	HepG2	liver:	n/a	n/a
14	CTCF	chr12:568775-568804	Kidney_OC	kidney:	n/a	n/a
15	E2F6	chr12:568465-569081	A549	lung:	n/a	n/a
16	E2F6	chr12:568487-569024	H1-hESC	embryonic stem cell:	n/a	n/a
17	E2F6	chr12:570190-571017	H1-hESC	embryonic stem cell:	n/a	n/a
18	E2F6	chr12:569531-570084	H1-hESC	embryonic stem cell:	n/a	chr12:569870-569879
19	E2F6	chr12:568342-569224	H1-hESC	embryonic stem cell:	n/a	n/a
20	E2F6	chr12:569519-570179	H1-hESC	embryonic stem cell:	n/a	chr12:569870-569879
21	E2F6	chr12:569460-569629	K562	blood:	n/a	n/a
22	EGR1	chr12:568901-569305	K562	blood:	n/a	chr12:568929-568942
23	EGR1	chr12:568614-569455	HCT-116	colon:	n/a	chr12:569343-569352 chr12:568929-568942
24	EGR1	chr12:568859-569302	K562	blood:	n/a	chr12:568929-568942
25	EGR1	chr12:568558-569445	ECC-1	luminal epithelium:	n/a	chr12:569343-569352 chr12:568929-568942
26	EGR1	chr12:568837-569452	ECC-1	luminal epithelium:	n/a	chr12:569343-569352 chr12:568929-568942
27	ELF1	chr12:569498-569684	K562	blood:	n/a	chr12:569605-569618
28	ELF1	chr12:569489-569740	K562	blood:	n/a	chr12:569605-569618
29	ELF1	chr12:569314-569799	GM12878	blood:	n/a	chr12:569349-569361 chr12:569605-569618
30	GATA2	chr12:568215-568946	SH-SY5Y	brain:	n/a	n/a
31	GATA2	chr12:568286-568865	HUVEC	blood vessel:	n/a	n/a
32	GATA3	chr12:568267-568647	T-47D	breast:	n/a	chr12:568476-568484
33	GATA3	chr12:568250-568434	MCF-7	breast:	n/a	n/a
34	GATA3	chr12:568243-568803	T-47D	breast:	n/a	chr12:568476-568484
35	GATA3	chr12:568248-568621	MCF-7	breast:	n/a	chr12:568476-568484
36	GATA3	chr12:568139-568993	MCF-7	breast:	n/a	chr12:568182-568195 chr12:568476-568484
37	GATA3	chr12:568286-568613	SH-SY5Y	brain:	n/a	chr12:568476-568484
38	HNF4G	chr12:570567-570841	HepG2	liver:	n/a	chr12:570723-570735 chr12:570722-570737 chr12:570799-570807 chr12:570722-570736 chr12:570723-570735 chr12:570722-570737 chr12:570722-570737 chr12:570722-570737 chr12:570724-570736 chr12:570722-570735 chr12:570720-570735
39	KAP1	chr12:568243-568989	U2OS	brain:	n/a	n/a
40	MAFK	chr12:570488-570557	H1-hESC	embryonic stem cell:	n/a	n/a
41	MAX	chr12:570508-570935	HepG2	liver:	n/a	chr12:570735-570746 chr12:570736-570746 chr12:570735-570746 chr12:570736-570745 chr12:570736-570745 chr12:570737-570744
42	MAX	chr12:570621-570888	HepG2	liver:	n/a	chr12:570735-570746 chr12:570736-570746 chr12:570735-570746 chr12:570736-570745 chr12:570736-570745 chr12:570737-570744
43	MAX	chr12:568513-568976	MCF-7	breast:	n/a	chr12:568932-568942
44	MAX	chr12:568503-568997	A549	lung:	n/a	chr12:568932-568942
45	MAX	chr12:568436-569478	A549	lung:	n/a	chr12:568932-568942
46	MAX	chr12:570469-571012	HepG2	liver:	n/a	chr12:570735-570746 chr12:570736-570746 chr12:570735-570746 chr12:570736-570745 chr12:570736-570745 chr12:570737-570744
47	MAX	chr12:568504-569469	H1-hESC	embryonic stem cell:	n/a	chr12:568932-568942
48	MAX	chr12:569800-570098	HepG2	liver:	n/a	chr12:569928-569938 chr12:569929-569939 chr12:569928-569939 chr12:569928-569939 chr12:569929-569938 chr12:569870-569880 chr12:569929-569938 chr12:569929-569938
49	MAX	chr12:568464-570097	ECC-1	luminal epithelium:	n/a	chr12:569928-569938 chr12:569929-569939 chr12:569928-569939 chr12:569928-569939 chr12:569929-569938 chr12:569870-569880 chr12:569929-569938 chr12:568932-568942 chr12:569929-569938
50	MAX	chr12:568526-568948	H1-hESC	embryonic stem cell:	n/a	chr12:568932-568942

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:568543-568593	K562	blood:	n/a
2	chr12:568543-568593	K562	blood:	n/a
3	chr12:568543-568593	PrEC	prostate:	n/a
4	chr12:568798-568848	U87	brain:	n/a
5	chr12:569111-569161	PFSK-1	brain:	n/a
6	chr12:568931-568981	GM12878	blood:	n/a
7	chr12:569733-569783	HNPCEpiC	eye:	n/a
8	chr12:570155-570205	AG04450	lung:	fetal
9	chr12:568798-568848	ovcar-3	ovarian:	n/a
10	chr12:570155-570205	SKMC	muscle:	n/a
11	chr12:569733-569783	Hepatocyte	liver:	n/a
12	chr12:570155-570205	HUVEC	blood vessel:	n/a
13	chr12:570249-570299	MCF10A-Er-Src	breast:	n/a
14	chr12:569221-569271	CMK	blood:	n/a
15	chr12:568826-568876	PANC-1	pancreas:	n/a
16	chr12:569733-569783	LNCaP	prostate:	n/a
17	chr12:570249-570299	HRE	kidney:	n/a
18	chr12:569733-569783	MCF-7	breast:	n/a
19	chr12:568826-568876	AG09319	gingival:	n/a
20	chr12:569221-569271	LNCaP	prostate:	n/a
21	chr12:568931-568981	SK-N-SH	brain:	n/a
22	chr12:568826-568876	NT2-D1	testis:	n/a
23	chr12:568798-568848	Caco-2	colon:	n/a
24	chr12:568826-568876	SK-N-MC	brain:	n/a
25	chr12:570155-570205	AG10803	skin:	n/a
26	chr12:569679-569729	HCF	heart:	n/a
27	chr12:569733-569783	NH-A	brain:	n/a
28	chr12:568931-568981	BJ	skin:	n/a
29	chr12:568826-568876	HAEpiC	amniotic membrane:	n/a
30	chr12:569679-569729	GM12891	blood:	n/a
31	chr12:570155-570205	RPTEC	kidney:	n/a
32	chr12:568798-568848	LNCaP	prostate:	n/a
33	chr12:569733-569783	HEEpiC	esophagus:	n/a
34	chr12:568931-568981	HCT-116	colon:	n/a
35	chr12:569111-569161	U87	brain:	n/a
36	chr12:568931-568981	IMR90	lung:	fetal
37	chr12:568798-568848	Jurkat	blood:	n/a
38	chr12:569111-569161	PrEC	prostate:	n/a
39	chr12:569733-569783	Caco-2	colon:	n/a
40	chr12:569733-569783	GM12892	blood:	n/a
41	chr12:568931-568981	NHDF-neo	bronchial:	n/a
42	chr12:568543-568593	AG10803	skin:	n/a
43	chr12:568826-568876	H1-hESC	embryonic stem cell:	embryo
44	chr12:569111-569161	GM12891	blood:	n/a
45	chr12:570155-570205	HEEpiC	esophagus:	n/a
46	chr12:569221-569271	SKMC	muscle:	n/a
47	chr12:568543-568593	SK-N-MC	brain:	n/a
48	chr12:568543-568593	HRCEpiC	kidney:	n/a
49	chr12:569733-569783	ProgFib	skin:	n/a
50	chr12:569221-569271	HRCEpiC	kidney:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:563329..565508-chr12:567009..569483,2	MCF-7	breast:
2	chr12:567792..568717-chr12:633148..633750,3	MCF-7	breast:

Variant related genes	Relation type
B4GALNT3	TF binding region
B4GALNT3	CpG island

Extended variants
information (count: 89 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs115698791	chr12:568248-568249	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs113543114	chr12:568273-568274	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs140004942	chr12:568296-568297	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs536412141	chr12:568311-568312	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs112382503	chr12:568320-568321	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs78186985	chr12:568333-568334	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs540678210	chr12:568430-568431	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs548300430	chr12:568447-568448	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs569629940	chr12:568457-568458	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs537098938	chr12:568460-568461	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs558261404	chr12:568467-568468	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs576391413	chr12:568510-568511	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs143503194	chr12:568625-568626	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs369568918	chr12:568638-568639	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs113901439	chr12:568644-568645	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs552812025	chr12:568645-568646	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs574324278	chr12:568763-568764	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs541634888	chr12:568781-568782	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs147288715	chr12:568789-568790	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs561476697	chr12:568803-568804	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs569255831	chr12:568934-568935	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs576449813	chr12:568981-568982	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs543858598	chr12:569005-569006	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs565281537	chr12:569021-569022	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs560322126	chr12:569050-569051	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs570765729	chr12:569094-569095	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs532519908	chr12:569107-569108	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs55927905	chr12:569127-569128	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs560074352	chr12:569130-569131	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs530347443	chr12:569131-569132	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs548496699	chr12:569198-569199	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs569775499	chr12:569221-569222	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs144587580	chr12:569287-569288	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs551811054	chr12:569312-569313	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs570125927	chr12:569320-569321	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs534300230	chr12:569429-569430	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs111479236	chr12:569480-569481	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs552875897	chr12:569517-569518	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs568259087	chr12:569617-569618	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs535679791	chr12:569618-569619	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs376271214	chr12:569625-569626	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs144955552	chr12:569626-569627	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs370603270	chr12:569632-569633	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs201909336	chr12:569652-569653	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs11609193	chr12:569686-569687	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs12307182	chr12:569725-569726	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs543574094	chr12:569807-569808	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs559061010	chr12:569911-569912	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs577345558	chr12:569927-569928	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs12825673	chr12:569945-569946	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Cancer	20164919	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:454 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:560400-568200	Weak transcription	Gastric	stomach
2	chr12:560600-568400	Weak transcription	Rectal Mucosa Donor 31	rectum
3	chr12:563000-568400	Weak transcription	Pancreas	Pancrea
4	chr12:563200-568600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr12:563200-568600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
6	chr12:563200-568600	Weak transcription	Right Ventricle	heart
7	chr12:563400-568200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr12:564200-568400	Weak transcription	Esophagus	oesophagus
9	chr12:565000-568600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr12:566000-568600	Enhancers	Fetal Heart	heart
11	chr12:566600-568600	Weak transcription	Left Ventricle	heart
12	chr12:567200-568600	Enhancers	Stomach Mucosa	stomach
13	chr12:568000-568600	Enhancers	Primary T killer memory cells from peripheral blood	blood
14	chr12:568200-568400	Enhancers	Breast Myoepithelial Primary Cells	Breast
15	chr12:568200-568400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
16	chr12:568200-568400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
17	chr12:568200-568400	Enhancers	Primary T helper naive cells from peripheral blood	blood
18	chr12:568200-568400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
19	chr12:568200-568400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
20	chr12:568200-568400	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
21	chr12:568200-568400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr12:568200-568600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
23	chr12:568200-568600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
24	chr12:568200-568600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr12:568200-568600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
26	chr12:568200-568600	Weak transcription	Brain Cingulate Gyrus	brain
27	chr12:568200-568600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr12:568200-568600	Bivalent Enhancer	Fetal Brain Male	brain
29	chr12:568200-568600	Bivalent Enhancer	Placenta	Placenta
30	chr12:568200-568600	Enhancers	Gastric	stomach
31	chr12:568200-568800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
32	chr12:568200-569000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
33	chr12:568400-568600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr12:568400-568600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr12:568400-568600	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr12:568400-568600	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr12:568400-568600	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr12:568400-568600	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr12:568400-568600	Bivalent/Poised TSS	Primary B cells from cord blood	blood
40	chr12:568400-568600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
41	chr12:568400-568600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
42	chr12:568400-568600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr12:568400-568600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr12:568400-568600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr12:568400-568600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
46	chr12:568400-568600	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr12:568400-568600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr12:568400-568600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr12:568400-568600	Enhancers	Liver	Liver
50	chr12:568400-568600	Enhancers	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links